Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 31 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 6165781

    Modified adeno-associated virus vector capable of expression from a novel promoter

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired
  2. US 6162620

    Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor

    Cogent Partners, LP · Granted Dec 19, 2000 · Expires Dec 14, 2020

    expired
  3. US 6156321

    Tissue factor methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Dec 5, 2000 · Expires Nov 30, 2020

    expired
  4. US 6143714

    Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 7, 2000 · Expires Nov 2, 2020

    expired
  5. US 6132962

    Retroviral vectors comprising an anti-hiv or other nucleic acid

    The Regents of the University of California · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired
  6. US 6133256

    Selective factor Xa inhibitors

    COR Therapeutics, Inc. · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired
  7. US 6133276

    Compounds and methods for increasing endogenous levels of corticotropin-releasing factor

    Neurocrine Biosciences, Inc. · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired
  8. US 6133232

    Endoderm, cardiac and neural inducing factors

    The Regents of the University of California · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired
  9. US 6132715

    Method of inhibiting biosynthesis of tumor necrosis factor

    Nika Health Products Limited · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired
  10. US 6132729

    Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired
  11. US 6132730

    Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired
  12. US 6126944

    Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 3, 2000 · Expires Sep 28, 2020

    expired
  13. US 6120777

    High fluorescence specific immune enhancing factor and methods of use for same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 19, 2000 · Expires Sep 14, 2020

    expired
  14. US 6117836

    Glycosylation-mediated inhibition of factor X

    COR Therapeutics, Inc. · Granted Sep 12, 2000 · Expires Sep 7, 2020

    expired
  15. US 6117839

    Bone stimulating factor

    Gensci Regeneration Science, Inc. · Granted Sep 12, 2000 · Expires Sep 7, 2020

    expired
  16. US 6096534

    Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 1, 2000 · Expires Jul 27, 2020

    expired
  17. US 6083750

    Adenovirus vectors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 4, 2000 · Expires Jun 29, 2020

    expired
  18. US 6071891

    Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition

    Regents of the University of Minnesota · Granted Jun 6, 2000 · Expires Jun 1, 2020

    expired
  19. US 6071742

    Coxsackie virus as a vector for delivery of anti-inflammatory cytokines

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 6, 2000 · Expires Jun 1, 2020

    expired
  20. US 6071709

    Nerve growth factor/receptor complex

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 6, 2000 · Expires Jun 1, 2020

    expired
  21. US 6069130

    Ketoheterocyclic inhibitors of factor Xa

    COR Therapeutics, Inc. · Granted May 30, 2000 · Expires May 25, 2020

    expired
  22. US 6066623

    Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines

    United States of America as represented by the Secretary of the Air Force · Granted May 23, 2000 · Expires May 18, 2020

    expired
  23. US 6066778

    Transgenic mice expressing APC resistant factor V

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 23, 2000 · Expires May 18, 2020

    expired
  24. US 6063622

    Adenovirus vectors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 16, 2000 · Expires May 11, 2020

    expired